Carmen Jackson
INTERIM CEO CLQ at AMERICAN SOCIETY OF CLINICAL ONCOLOGY · VA · Disease Research
$412K
Peak Total Compensation
4
Years Tracked
5x
vs. Median Household
Carmen Jackson has appeared in compensation disclosures over 4 years of available data (2018–2022). Total compensation changed from $316,699 to $405,036 - a 27.9% increase.
Peak total compensation of $411,994 equals 5x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2022 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY | INTERIM CEO CLQ | $359,782 | $45,254 | $405,036 |
| 2020 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC | Chief of Operations, CLQ | $366,493 | $45,501 | $411,994 |
| 2019 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC | COO, CANCERLINQ | $314,738 | $43,811 | $358,549 |
| 2018 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC | CANCERLINQ CHIEF OF OPERATIONS | $273,500 | $43,199 | $316,699 |
Peers at AMERICAN SOCIETY OF CLINICAL ONCOLOGY
| Name | Title | Peak Comp. |
|---|---|---|
| Clifford Hudis Md | Chief Executive Officer | $972K |
| Clifford A Hudis Md | CEO | $953K |
| Clifford Hudismd | CEO, NON-VOTING DIRECTOR | $922K |
| Clifford Ahudismdfacpfasco | CEO, Ex-officio Director | $832K |
| Dina Michels Esq | SECRETARY, EVP & COO | $669K |
| Richard Schilsky Md | EVP & Chief Medical Officer | $660K |
| Julie R Gralow Md | EVP & CMO | $623K |
| Allen S Lichter Md Fasco | CEO, Ex-officio Dir (non-vote) | $601K |
| Cory Wiegert | EVP & CEO, CancerLinQ | $564K |
| Sean Khozin Md | EVP & CLQ CEO (PARTIAL YEAR) | $537K |
Email Alerts
Get notified about Carmen Jackson
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →